The company, JAMP Pharma Corporation, found that some bottles of JAMP Guanfacine extended-release (XR) one-milligram tablets contained four-milligram tablets. One lot, or 100,000 units ...

Researchers in the UK have shown that guanfacine could help to combat leftward spatial exploration deficit in patients with visual neglect due to right-hemisphere stroke. The noradrenergic ...

It is FDA-approved to treat ADHD alone or in combination with a stimulant medication. Onyda XR can be used in people 6 years ...

The Dementia Trials Accelerator (DTA) – which will be spearheaded by the UK Dementia Research Institute (UK DRI) and Health ...

Non-stimulant medications like Atomoxetine and Guanfacine are usually recommended for people who experience severe side effects when using stimulants. Antidepressants like Wellbutrin XR and ...

Mixed salts of a single-entity amphetamine product (each cap contains equal parts dextroamphetamine saccharate, dextroamphetamine sulfate, amphetamine aspartate monohydrate, amphetamine sulfate ...

This formulation of Guanfacine isn't prescribed to children under the age of 12. Extended-release: This is marketed under the brand name Intuniv. It is usually prescribed to be taken once a day in ...

Samsung has confirmed it still has plans to release an XR device that will be available sometime next year. The company shared tidbits of information about the XR eXtended reality project in its ...

Swallow whole. May use methylphenidate extended-release tabs in place of methylphenidate tabs when the 8-hr dose of methylphenidate extended-release corresponds to the titrated 8-hr dose of ...

A new Samsung XR/VR device is coming according to the manufacturer itself, and we couldn't be more excited too see what this so-called Apple Vision Pro rival (an XR headset from Apple) will have ...

Varjo is already quite familiar with VR training for helicopter flights because the U.S. Army’s Reconfigurable Virtual Collective Trainer Air Program already selected Varjo’s XR-3 last year ...

For an extended-release formulation given once daily to offer any advantage in terms of patient convenience, better safety profile due to reduced peak concentrations and/or better or equivalent ...